Mizuho on Verastem (VSTM): 'we continue to favor it as a top small cap biotech idea'
Tweet Send to a Friend
Mizuho analyst Graig Suvannavejh reiterated an Outperform rating and $8.00 price target on Verastem (NASDAQ: VSTM)The analyst comments "With the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
